CARDIAC PERFORMANCE IN END STAGE RENAL DISEASE DIABETIC PATIENTS WITH ARTERIOVENOUS FISTULA

被引:0
|
作者
Beigi, Ali-Akbar [1 ]
Khosravi, Alireza [2 ]
Sadeghi, Amir Mir-Mohammad [3 ]
Safaei, Mansour [4 ]
机构
[1] Isfahan Univ Med Sci, Chamran Hosp, Vasc Surg Dept, Esfahan, Iran
[2] Isfahan Univ Med Sci, Isfahan Cardiovasc Res Ctr, Esfahan, Iran
[3] Kashan Univ Med Sci, Dept Gen Surg, Kashan, Iran
[4] Isfahan Univ Med Sci, Dept Surg, Esfahan, Iran
关键词
Fistulization; End Stage Renal Diseases; Cardiac Performance; Diabetes mellitus;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: Access to vascular system needed for hemodialysis among patients in end stage renal disease (ESRD). Cardiac performance has been affected by chronic renal failure based on several known causes during diseases process. We have compared in this study some of cardiac performance indicators before and after fistulization in diabetic and non-diabetic ESRD patients. METHODS: Fifty ESRD patients were included in the study. Systolic pulmonary arterial pressure (PAP), cardiac output (CO) and ejection fraction (EF) were measured by echocardiography before fistulization and was repeated at least 8 months after fistulization. Data analyzed in diabetic and non-diabetic patients. RESULTS: Thirty four patients were included in analysis (28 men and 6 women). Mean time of follow up was 10.5 +/- 1.3 months. The mean of PAP before and after fistulization was 25.16 mmHg and 21.3 mmHg, respectively in all individuals (P > 0.05). The mean of cardiac output before and after making fistula was 5580 ml/min and 5680 ml/min, respectively (P < 0.05). Diabetic patients showed a significant reduction in their mean of cardiac ejection fraction before and after intervention (EF1 = 66.9%, EF2 = 51.4%) comparing with non-diabetic patients (EF1 = 58.5, EF2 = 57.5) (P < 0.05). PAP changes and CO changes had not any significant difference between diabetic and non-diabetic patients. DISCUSSION: Fistulization in ESRD patients can improve cardiac performance among these patients. This change may be differing among patients based on the cause of renal failure. Diabetes mellitus may be one of the parameters that can modulate this affect. This should be test in more detailed studies.
引用
收藏
页码:33 / 36
页数:4
相关论文
共 50 条
  • [21] Strategies to increase the use of autogenous arteriovenous fistula in end-stage renal disease
    Miller, A
    Holzenbein, T
    Gottlieb, MN
    Sacks, BA
    Lavin, PT
    Goodman, WS
    Gupta, SK
    ANNALS OF VASCULAR SURGERY, 1997, 11 (04) : 397 - 405
  • [22] Aortic Arch Calcification Predicts Patency Loss of Arteriovenous Fistula in End-Stage Renal Disease Patients
    Yap, Yit-Sheung
    Ting, Kai-Ting
    Chi, Wen-Che
    Lin, Cheng-Hao
    Liu, Yi-Chun
    Chuang, Wan-Long
    SCIENTIFIC REPORTS, 2016, 6
  • [23] Aortic Arch Calcification Predicts Patency Loss of Arteriovenous Fistula in End-Stage Renal Disease Patients
    Yit-Sheung Yap
    Kai-Ting Ting
    Wen-Che Chi
    Cheng-Hao Lin
    Yi-Chun Liu
    Wan-Long Chuang
    Scientific Reports, 6
  • [24] Frequency of Dysfunctional Arteriovenous Fistula among End Stage Renal Disease Patients on Thrice Weekly Maintenance Hemodialysis
    Kafayat, Sana
    Anwar, Shahid
    Abad-ur-Rehman
    Anwar, Zahid
    Akram, Mateen
    Mazhar, Sobia
    PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES, 2022, 16 (01): : 116 - 118
  • [25] Association Between Heart Failure and Arteriovenous Fistula Patency in Patients With End-stage Renal Disease on Hemodialysis
    Fisher, Andrea
    Mulaney, Bianca
    Sheehan, Brian
    Garcia-Toca, Manuel
    Sorial, Ehab
    Sgroi, Michael
    JOURNAL OF VASCULAR SURGERY, 2023, 77 (06) : E71 - E72
  • [26] Long-term cardiovascular changes following creation of arteriovenous fistula in patients with end stage renal disease
    Reddy, Yogesh N. V.
    Obokata, Masaru
    Dean, Patrick G.
    Melenovsky, Vojtech
    Nath, Karl A.
    Borlaug, Barry A.
    EUROPEAN HEART JOURNAL, 2017, 38 (24) : 1913 - 1923
  • [27] Arteriovenous fistula is associated with diastolic dysfunction in end-stage renal failure patients
    Robinson, Jake
    Sehly, Amro
    Lan, Nick S. R.
    Abraham, Abu
    Dwivedi, Girish
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2023, 27 (2) : 200 - 201
  • [28] Arteriovenous fistula is associated with diastolic dysfunction in end-stage renal failure patients
    Jake Robinson
    Amro Sehly
    Nick S. R. Lan
    Abu Abraham
    Girish Dwivedi
    Clinical and Experimental Nephrology, 2023, 27 : 200 - 201
  • [29] Arteriovenous malformations in End Stage Renal disease
    Maheshwari, N.
    Varma, R.
    Kulkarni, S.
    Kumari, D.
    Ong, E.
    Roffe, E.
    Chaudhari, S.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2012, 60 : S19 - S20
  • [30] Risk Factors and Utility of Intraoperative Arteriovenous Fistula Blood Flow Level as a Surrogate Marker of Arteriovenous Fistula Failure in Patients with End-stage Renal Disease
    Shindo, Mitsutoshi
    Morino, Junki
    Minato, Saori
    Kaneko, Shohei
    Mutsuyoshi, Yuko
    Yanai, Katsunori
    Ishii, Hiroki
    Matsuyama, Momoko
    Kitano, Taisuke
    Miyazawa, Haruhisa
    Ito, Kiyonori
    Shimoyama, Hirofumi
    Ueda, Yuichiro
    Hirai, Keiji
    Hoshino, Taro
    Ookawara, Susumu
    Morishita, Yoshiyuki
    SAUDI JOURNAL OF KIDNEY DISEASES AND TRANSPLANTATION, 2022, 33 : S147 - S158